Candel Therapeutics ($CADL) Stock Declines -32% Over 30 Days on Delayed FDA Filing Candel Therapeutics shares have fallen roughly 32% over the last 30 days, fr

Candel Therapeutics ($CADL) Stock Declines -32% Over 30 Days on Delayed FDA Filing Candel Therapeutics shares have fallen roughly 32% over the last 30 days, from about $9.07 to $6.21, driven primarily by a delayed FDA filing timeline for its lead drug candidate. The sharpest decline followed the c…